Efficacy of Galcanezumab in Patients Who Failed to Respond to Preventives Previously: Results from EVOLVE-1, EVOLVE-2 and REGAIN Studies (S20.004)
Qi Zhang(Zhejiang Chinese Medical University), Sheena K. Aurora(Impel Neuropharma (United States)), Eric Pearlman(University of California, San Francisco), Sriram Govindan(Eli Lilly (India)), Dustin Ruff(Eli Lilly (United States))
Cited by 15
Related Papers
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
CGRP and the Trigeminal System in Migraine
|Headache The Journal of Head and Face Pain|2019|483
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
|Nature Communications|2016|446